• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX26
Device Problems Valve; Adverse Event Without Identified Device or Use Problem
Event Date 03/08/2017
Event Type  Death  
Manufacturer Narrative

Per the instructions for use (ifu) cardiovascular injury, such as perforation dissection of vessels, ventricle, myocardium or valvular structures, is a known potential complication associated with the tavr procedure. According to the thv training manuals, risk factors for aortic dissection, hematoma or annular rupture during the tavr procedure include significant thv over sizing, severely obliterated sinuses of valsalva, porcelain aorta and/or presence of bulky calcification and narrow calcified stj. In addition, advanced age, female gender, small body weight, and steroid dependency can also be contributing factors. The sapien valve relies on native valve calcium to securely anchor to the annulus. Despite this beneficial aspect of calcium, bulky calcium can increase the risk of calcific nodule displacement into the vasculature, which can lead to vascular injury. At times the extent and distribution of calcium can impair ease of delivery of the valve, correct positioning of the valve, deployment of the valve and procedural success. In this case, with the limited information the annular rupture was most likely caused by the mechanisms above. It is also likely related to the presence of heavy calcification at the native leaflets. The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device. Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review. No corrective or preventative actions are required.

 
Event Description

As reported the edwards canadian affiliate, a 26 mm sapien 3 valve was prepped to be implanted in the aortic position through right trans-femoral approach using the cutdown technique. The 14fr esheath was inserted, a bav was performed successfully prior to inserting the commander system. The deployment was successful and post echo images revealed good positioning with no pvl. Approximately 5 minutes post implant, while proceeding to femoral closure, a significant drop in pressure was noted as well as a pericardial effusion. A thoracotomy was immediately performed. The patient was stabilized and sent to ccu to recover following the procedure. Later during the day the patient was taken to the operation room as bleeding reoccurred. Initially it was believed the wire had punctured the lv but it was later confirmed the patient suffered an annular rupture during tavi. The patient unfortunately passed away. It is believed the cause of the annular rupture was probably heavy calcification and its interaction with the 26mm sapien 3 valve. With the annular area measuring around 440mm2, this was felt to be appropriate for a 26mm sapien 3 thv. It was hypothesized by the physicians that perhaps a 23mm sapien 3 might have been better to avoid annulus rupture.

 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameEDWARDS SAPIEN 3 TRANSCATHETER
Type of DeviceAORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
frances preston
1 edwards way
irvine , CA 92614
9492505190
MDR Report Key6439627
Report Number2015691-2017-00815
Device Sequence Number1
Product CodeNPT
Report Source Manufacturer
Source Type COMPANY REPRESENTATIVE,FOREIG
Reporter Occupation
Remedial Action Other
Type of Report Initial
Report Date 03/08/2017
1 Device Was Involved in the Event
1 Patient Was Involved in the Event
Date FDA Received03/28/2017
Is This An Adverse Event Report? Yes
Is This A Product Problem Report? No
Device Operator HEALTH PROFESSIONAL
Device EXPIRATION Date09/30/2018
Device MODEL Number9600TFX26
Device LOT Number5170480
Was Device Available For Evaluation? No
Is The Reporter A Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received03/08/2017
Was Device Evaluated By Manufacturer? No Answer Provided
Date Device Manufactured10/20/2016
Is The Device Single Use? Yes
Is this a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient TREATMENT DATA
Date Received: 03/28/2017 Patient Sequence Number: 1
-
-